IL1B and Parkinson disease: Recently [6], we demonstrated that caffeine, a nonselective adenosine A2A antagonist, as PTX, attenuates the striatal dopaminergic loss and decreases proinflammatory cytokines, as TNF-alpha and IL-1 beta, in the PD model of 6-OHDA lesion.